Literature DB >> 8485812

Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.

P Calsou1, B Salles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8485812     DOI： 10.1007/bf00685607

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  67 in total

1.  Phenotypic reversion of cisplatin resistance in human cells accompanies reduced host cell reactivation of damaged plasmid.

Authors:  C C Chao; Y L Lee; S Lin-Chao
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

2.  DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells.

Authors:  L C Erickson; G Laurent; N A Sharkey; K W Kohn
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

3.  Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese hamster ovary cells.

Authors:  B Z Jiang; B B Bank; Y H Hsiang; T Shen; M Potmesil; R Silber
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

Review 4.  Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

Authors:  A L Pinto; S J Lippard
Journal:  Biochim Biophys Acta       Date:  1985

5.  Extracts of chronic lymphocytic leukemia lymphocytes have a high level of DNA repair activity fo O6-methylguanine.

Authors:  E A Waldstein; E H Cao; M E Miller; E P Cronkite; R B Setlow
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.

Authors:  W R Waud
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

7.  The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.

Authors:  M M Jennerwein; A Eastman; A R Khokhar
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

8.  Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II).

Authors:  C C Chao; Y L Lee; P W Cheng; S Lin-Chao
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

9.  DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA.

Authors:  N Sheibani; M M Jennerwein; A Eastman
Journal:  Biochemistry       Date:  1989-04-04       Impact factor: 3.162

10.  Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract.

Authors:  I Husain; W Carlton; A Sancar
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971
View more
  9 in total

1.  Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.

Authors:  F Bernges; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining.

Authors:  Heather J Boeckman; Kelly S Trego; John J Turchi
Journal:  Mol Cancer Res       Date:  2005-05       Impact factor: 5.852

3.  Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.

Authors:  M Osmak; I Vrhovec; J Skrk
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

4.  Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin.

Authors:  L Duan; M Aoyagi; M Tamaki; K Nakagawa; G Nagashima; Y Nagasaka; K Ohno; K Yamamoto; K Hirakawa
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

5.  Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.

Authors:  Q Dong; N Bullock; F Ali-Osman; O M Colvin; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

6.  Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells.

Authors:  L Beketic-Oreskovic; M Osmak
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment.

Authors:  O Pauwels; R Kiss
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.

Authors:  J Holford; S Y Sharp; B A Murrer; M Abrams; L R Kelland
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities.

Authors:  Muhammad Assad Riaz; Ali Sak; Yasin Bahadir Erol; Michael Groneberg; Jürgen Thomale; Martin Stuschke
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.